Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Transcriptional activation of the Hepatocyte Growth Factor receptor (c-met) gene by its ligand (Hepatocyte Growth Factor) is mediated through AP-1

Abstract

Hepatocyte Growth Factor (HGF) exerts its biological effects via binding and activating a transmembrane protein tyrosine kinase receptor known as c-Met. Previous studies from our laboratory demonstrated that c-met gene expression is inducible by its own ligand (HGF). However, the molecular mechanism(s) involved in this process are unknown. The present study was carried out to address this question. Transfection of various c-met-CAT promoter constructs into the mouse hepatocellular carcinoma cell line Hepa 1-6 in combination with electrophoretic mobility shift assays (EMSA) identified the responsive element as an activated protein-1 (AP-1) binding site (TGAGTCA) within the c-met core promoter region at position −158 to −152. The c-met AP-1 element binds specifically to AP-1 protein as verified by supershift assays. EMSA studies and mutational analyses of the promoter region also revealed that the members of the Sp family of transcription factors (Sp-1 and Sp-3) bind to the c-met Sp-1 element (located at position −124) which is adjacent to the AP-1 site. We show that Sp binding dampens binding of AP-1 to its cognate site in the c-met promoter region. Stimulation of Hepa 1-6 cells with HGF resulted in a rapid and dramatic enhancement of the AP-1 binding activity as well as an overall increase in the level of AP-1 protein. Cotransfection of AP-1 expression vectors (c-Fos plus c-Jun) with c-met promoter constructs resulted in stimulation of c-met promoter activity. We found that transactivation of the c-met promoter by AP-1 can be blocked by Curcumin, an inhibitor of AP-1. Moreover, we found that the induction of the endogenous c-met gene by HGF is inhibited by the addition of Curcumin. The results demonstrate that the HGF-induced transcription of the c-met gene by HGF is, at least in part, due to activation of the AP-1 pathway.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Ahmad M, Theofanidis P and Medford RM. . 1998 J. Biol. Chem. 273: 4616–4621.

  • Bell A, Chen Q, DeFrances MC, Michalopoulos GK and Zarnegar R. . 1999 Oncogene 18: 887–895.

  • Bladt F, Riethmacher D, Isenmann S, Aguzzi A and Birchmeier C. . 1995 Nature 373: 702–705.

  • Blume SW, Snyder RC, Ray R, Thomas S, Koller CA and Miller DM. . 1991 J. Clin. Invest. 88: 1613–1621.

  • Boccaccio C, Gaudino G, Gambarotta G, Galimi F and Comoglio PM. . 1994 J. Biol. Chem. 269: 12846–12851.

  • Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande Woude GF and Aaronson SA. . 1991 Science 251: 802–804.

  • Chen Q, Seol DW, Carr B and Zarnegar R. . 1997 Hepatology 26: 59–66.

  • Chen YR and Tan TH. . 1998 Oncogene 17: 173–178.

  • Gambarotta G, Boccaccio C, Giordano S, Ando M, Stella MC and Comoglio PM. . 1996 Oncogene 13: 1911–1917.

  • Greenwel P, Inagaki Y, Hu W, Walsh M and Ramirez F. . 1997 J. Biol. Chem. 272: 19738–19745.

  • Huang TS, Lee SC and Lin JK. . 1991 Proc. Natl. Acad. Sci. USA 88: 5292–5296.

  • Janson L and Pettersson U. . 1991 Gene 109: 297–301.

  • Jeffers M, Fiscella M, Webb CP, Anver M, Koochekpour S and Vande Woude GF. . 1998 Proc. Natl. Acad. Sci. USA 95: 14417–14422.

  • Jeffers M, Rao MS, Rulong S, Reddy JK, Subbarao V, Hudson E, Vande Woude GF and Resau JH. . 1996 Cell Growth Differ. 7: 1805–1813.

  • Jiang J-G, Chen Q, Bell A and Zarnegar R. . 1997 Oncogene 14: 3039–3049.

  • Karin M. . 1995 J. Biol. Chem. 270: 16483–16486.

  • Kida M, Souri M, Yamamoto M, Saito H and Ichinose A. . 1999 J. Biol. Chem. 274: 6138–6147.

  • Lee W, Mitchell P and Tjian R. . 1987 Cell 49: 741–752.

  • Leiden JM, Yang LH, Morle GD, June CH, Lindsten T, Thompson CB and Karpinski B. . 1989 J. Autoimmun. 2: (Suppl) 67–79.

  • Liu Y, Michalopoulos GK and Zarnegar R. . 1994 J. Biol. Chem. 269: 4152–4160.

  • Maffe A and Comoglio PM. . 1998 Eur. J. Morphol. 36: (Suppl) 74–81.

  • Marks-Konczalik J, Chu SC and Moss J. . 1998 J. Biol. Chem. 273: 22201–22208.

  • Naldini L, Weidner KM, Vigna E, Gaudino G, Bardelli A, Ponzetto C, Narsimhan RP, Hartmann G, Zarnegar R, Michalopoulos GK, et al. 1991 EMBO J. 10: 2867–2878.

  • Rodrigues GA, Park M and Schlessinger J. . 1997 EMBO J. 16: 2634–2645.

  • Seol DW, Chen Q, Smith ML and Zarnegar R. . 1999 J. Biol. Chem. 274: 3565–3572.

  • Seol DW and Zarnegar R. . 1998 Biochim. Biophys. Acta 1395: 252–258.

  • Sonnenberg JL, Rauscher FJD, Morgan JI and Curran T. . 1989 Science 246: 1622–1625.

  • Srivastava S, Weitzmann MN, Kimble RB, Rizzo M, Zahner M, Milbrandt J, Ross FP and Pacifici R. . 1998 J. Clin. Invest. 102: 1850–1859.

  • Tamagnone L and Comoglio PM. . 1997 Cytokine Growth Factor Rev. 8: 129–142.

  • Uehara Y, Minowa O, Mori C, Shiota K, Kuno J, Noda T and Kitamura N. . 1995 Nature 373: 702–705.

  • Weir E, Chen Q, DeFrances MC, Bell A, Taub R and Zarnegar R. . 1994 Hepatology 20: 955–960.

  • Zarnegar R and Michalopoulos GK. . 1995 J. Cell Biol. 129: 1177–1180.

  • Zhang Y, Feng XH and Derynck R. . 1998 Nature 394: 909–913.

Download references

Acknowledgements

The authors would like to thank Dr Marie C DeFrances for critical reading of this manuscript. This work was supported by a grant (RPG-91-009-10-CNE) from the American Cancer Society awarded to R Zarnegar.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seol, DW., Chen, Q. & Zarnegar, R. Transcriptional activation of the Hepatocyte Growth Factor receptor (c-met) gene by its ligand (Hepatocyte Growth Factor) is mediated through AP-1. Oncogene 19, 1132–1137 (2000). https://doi.org/10.1038/sj.onc.1203404

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203404

Keywords

This article is cited by

Search

Quick links